CYP21A2 and cancer: KCNH2 and CYP21A2 promoter regions consisting of 10 (chr16: 15,042,868–15,043,044) to 12 CpG sites (chr12: 1,451,023–1,451,292) were drastically hypermethylated in cancer samples when compared with normal (Figure 6A,B).